Harlan Weisman

Harlan Weisman

Directeur Général chez TFF PHARMACEUTICALS, INC.

Fortune : 99 384 $ au 30/04/2024

71 ans
Health Technology
Commercial Services
Consumer Services

Profil

Harlan F.
Weisman
is the founder of Mycrobiomics, Inc. (founded in 2016) and Flame Biosciences LLC (founded in 2019).
He held the title of Director & Chief Scientific Officer at Mycrobiomics, Inc. and President, Chief Executive Officer & Director at Flame Biosciences LLC.
Currently, Dr. Weisman holds the position of Vice Chairman, President & Chief Executive Officer at TFF Pharmaceuticals, Inc. since 2018.
He is also the Managing Director at And-One Consulting LLC since 2012, Director at Hackensack Meridian Health Center For Discovery & Innovation since 2019, Operating Partner at CR Group LP since 2012, and Venture Advisor at Israel Biotech Fund since 2016.
In his former positions, Dr. Weisman served as Chairman & Chief Executive Officer at Fortress Biotech, Inc. from 2012 to 2013.
He was also the Co-Chief Executive Officer at Flame Biosciences LLC, Chairman-Research & Development Council at J&J Maintenance, Inc., Chairman at Johnson & Johnson Pharmaceutical Research & Development LLC from 2004 to 2006, Chairman at 3D Bio Holdings, Inc. from 2014 to 2024, Director at ControlRad, Inc. from 2012 to 2019, Director at Caelum Biosciences, Inc. from 2019 to 2021, Therapeutic Advisory Board member at Teva Pharmaceutical Industries Ltd.
from 2016 to 2018, Advisory Committee Member at BioMotiv LLC from 2013 to 2019, and Member-Governors Board at Patient-Centered Outcomes Research Institute from 2010 to 2016.
He also held the title of Assistant Professor-Medicine at The Johns Hopkins University School of Medicine.
Dr. Weisman obtained his undergraduate degree from the University of Maryland in 1975 and his doctorate degree from the University of Maryland School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/04/2024 32 585 ( 1,29% ) 99 384 $ 30/04/2024

Postes actifs de Harlan Weisman

SociétésPosteDébut
TFF PHARMACEUTICALS, INC. Directeur Général 04/12/2022
Consultant / Advisor 01/10/2016
Hackensack Meridian Health Center For Discovery & Innovation Directeur/Membre du Conseil 01/01/2019
Private Equity Investor 01/01/2012
And-One Consulting LLC Corporate Officer/Principal 01/03/2012
Tous les postes actifs de Harlan Weisman

Anciens postes connus de Harlan Weisman

SociétésPosteFin
Président 01/04/2024
Directeur Général 31/01/2022
Directeur/Membre du Conseil 31/10/2021
Consultant / Advisor 31/12/2019
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Harlan Weisman

Formation de Harlan Weisman

University of Maryland Undergraduate Degree
University of Maryland School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Harlan Weisman

Relations

100 +

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

FORTRESS BIOTECH, INC.

Health Technology

TFF PHARMACEUTICALS, INC.

Health Technology

Entreprise privées14

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Finance

Finance

Technology Services

Health Technology

Commercial Services

And-One Consulting LLC

Johnson & Johnson Medical Devices & Diagnostics Group

Commercial Services

Hackensack Meridian Health Center For Discovery & Innovation

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Harlan Weisman